BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, De Giorgio R, Corinaldesi R, Stanghellini V. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:349-359. [PMID: 22148103 DOI: 10.5056/jnm.2011.17.4.349] [Cited by in Crossref: 119] [Cited by in F6Publishing: 112] [Article Influence: 11.9] [Reference Citation Analysis]
Number Citing Articles
1 Gras B, Magge S, Bloom A, Lembo A. Motility disorders of the colon and rectum. Curr Opin Gastroenterol. 2013;29:66-71. [PMID: 23207598 DOI: 10.1097/mog.0b013e32835a80e7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Herzlinger M, Cerezo C. Functional Abdominal Pain and Related Syndromes. Child and Adolescent Psychiatric Clinics of North America 2018;27:15-26. [DOI: 10.1016/j.chc.2017.08.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
3 Sinagra E, Morreale GC, Mohammadian G, Fusco G, Guarnotta V, Tomasello G, Cappello F, Rossi F, Amvrosiadis G, Raimondo D. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World J Gastroenterol 2017; 23(36): 6593-6627 [PMID: 29085207 DOI: 10.3748/wjg.v23.i36.6593] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
4 Gargari G, Taverniti V, Gardana C, Cremon C, Canducci F, Pagano I, Barbaro MR, Bellacosa L, Castellazzi AM, Valsecchi C, Tagliacarne SC, Bellini M, Bertani L, Gambaccini D, Marchi S, Cicala M, Germanà B, Dal Pont E, Vecchi M, Ogliari C, Fiore W, Stanghellini V, Barbara G, Guglielmetti S. Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome. Environ Microbiol 2018;20:3201-13. [PMID: 29749705 DOI: 10.1111/1462-2920.14271] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
5 Perez-Pujol S, Aras O, Escolar G. Factor v leiden and inflammation. Thrombosis. 2012;2012:594986. [PMID: 22666576 DOI: 10.1155/2012/594986] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
6 Liu DR, Xu XJ, Yao SK. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2018; 24(1): 46-57 [PMID: 29358881 DOI: 10.3748/wjg.v24.i1.46] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
7 Enck P, Aziz Q, Barbara G, Farmer AD, Fukudo S, Mayer EA, Niesler B, Quigley EM, Rajilić-Stojanović M, Schemann M, Schwille-Kiuntke J, Simren M, Zipfel S, Spiller RC. Irritable bowel syndrome. Nat Rev Dis Primers 2016;2:16014. [PMID: 27159638 DOI: 10.1038/nrdp.2016.14] [Cited by in Crossref: 338] [Cited by in F6Publishing: 296] [Article Influence: 67.6] [Reference Citation Analysis]
8 Cheng L, Luo QQ, Chen SL. The role of intestinal mast cell infiltration in irritable bowel syndrome. J Dig Dis 2021;22:143-51. [PMID: 33511763 DOI: 10.1111/1751-2980.12971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mullin GE, Shepherd SJ, Chander Roland B, Ireton-Jones C, Matarese LE. Irritable bowel syndrome: contemporary nutrition management strategies. JPEN J Parenter Enteral Nutr. 2014;38:781-799. [PMID: 25085503 DOI: 10.1177/0148607114545329] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
10 Sinagra E, Pompei G, Tomasello G, Cappello F, Morreale GC, Amvrosiadis G, Rossi F, Lo Monte AI, Rizzo AG, Raimondo D. Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol 2016; 22(7): 2242-2255 [PMID: 26900287 DOI: 10.3748/wjg.v22.i7.2242] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 48] [Article Influence: 10.8] [Reference Citation Analysis]
11 Hattay P, Prusator DK, Tran L, Greenwood-van Meerveld B. Psychological stress-induced colonic barrier dysfunction: Role of immune-mediated mechanisms. Neurogastroenterol Motil 2017;29:e13043. [DOI: 10.1111/nmo.13043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
12 Sahoo S, Padhy SK. Cross-cultural and psychological issues in irritable bowel syndrome. J Gastroenterol Hepatol 2017;32:1679-85. [PMID: 28244198 DOI: 10.1111/jgh.13773] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
13 Pescatori M, Podzemny V, Pescatori LC, Dore MP, Bassotti G. The PNEI holistic approach in coloproctology. Tech Coloproctol 2015;19:269-73. [PMID: 25820513 DOI: 10.1007/s10151-015-1277-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Guarino MPL, Cicala M, Putignani L, Severi C. Gastrointestinal neuromuscular apparatus: An underestimated target of gut microbiota. World J Gastroenterol 2016; 22(45): 9871-9879 [PMID: 28018095 DOI: 10.3748/wjg.v22.i45.9871] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
15 Lee KN, Lee OY. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J Gastroenterol 2014; 20(27): 8886-8897 [PMID: 25083061 DOI: 10.3748/wjg.v20.i27.8886] [Cited by in F6Publishing: 30] [Reference Citation Analysis]
16 Ringel-Kulka T, Choi CH, Temas D, Kim A, Maier DM, Scott K, Galanko JA, Ringel Y. Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome. Am J Gastroenterol. 2015;110:1339-1346. [PMID: 26303129 DOI: 10.1038/ajg.2015.220] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 10.5] [Reference Citation Analysis]
17 Vara EJ, Svanes C, Skorge TD, Berstad A, Florvaag E, Jarvis D, Omenaas E, Waatevik M, Johannessen A, Lied GA. Functional Gastrointestinal Symptoms Are Associated with Higher Serum Total IgE Levels, but Less Atopic Sensitization. Dig Dis Sci 2016;61:189-97. [DOI: 10.1007/s10620-015-3835-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
18 Bellini M, Gambaccini D, Stasi C, Urbano MT, Marchi S, Usai-Satta P. Irritable bowel syndrome: A disease still searching for pathogenesis, diagnosis and therapy. World J Gastroenterol 2014; 20(27): 8807-8820 [PMID: 25083055 DOI: 10.3748/wjg.v20.i27.8807] [Cited by in F6Publishing: 32] [Reference Citation Analysis]
19 Mcdonald EK, Rasmussen H, Forsyth C, Keshavarzian A. The In vivo Foundations for In vitro Testing of Functional Foods. In: Bordenave N, Ferruzzi MG, editors. Functional Foods and Beverages. Hoboken: John Wiley & Sons, Inc.; 2018. pp. 15-51. [DOI: 10.1002/9781118823309.ch2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Lee JY, Kim N, Nam RH, Sohn SH, Lee SM, Choi D, Yoon H, Kim YS, Lee HS, Lee DH. Probiotics reduce repeated water avoidance stress-induced colonic microinflammation in Wistar rats in a sex-specific manner. PLoS One 2017;12:e0188992. [PMID: 29244820 DOI: 10.1371/journal.pone.0188992] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
21 Dolan R, Chey WD, Eswaran S. The role of diet in the management of irritable bowel syndrome: a focus on FODMAPs. Expert Rev Gastroenterol Hepatol 2018;12:607-15. [PMID: 29764234 DOI: 10.1080/17474124.2018.1476138] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
22 Di Nardo G, Barbara G, Cucchiara S, Cremon C, Shulman RJ, Isoldi S, Zecchi L, Drago L, Oliva S, Saulle R. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS. Neurogastroenterol Motil. 2014;26:196-204. [PMID: 24304324 DOI: 10.1111/nmo.12250] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
23 Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. J Clin Gastroenterol. 2012;46 Suppl:S52-S55. [PMID: 22955358 DOI: 10.1097/mcg.0b013e318264e918] [Cited by in Crossref: 53] [Cited by in F6Publishing: 28] [Article Influence: 6.6] [Reference Citation Analysis]
24 Mahurkar S, Polytarchou C, Iliopoulos D, Pothoulakis C, Mayer EA, Chang L. Genome-wide DNA methylation profiling of peripheral blood mononuclear cells in irritable bowel syndrome. Neurogastroenterol Motil 2016;28:410-22. [PMID: 26670691 DOI: 10.1111/nmo.12741] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
25 Barragán-Martínez C, Speck-Hernández CA, Montoya-Ortiz G, Mantilla RD, Anaya JM, Rojas-Villarraga A. Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis. PLoS One 2012;7:e51506. [PMID: 23284705 DOI: 10.1371/journal.pone.0051506] [Cited by in Crossref: 76] [Cited by in F6Publishing: 61] [Article Influence: 8.4] [Reference Citation Analysis]
26 Simrén M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, Zoetendal EG; Rome Foundation Committee. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013;62:159-76. [PMID: 22730468 DOI: 10.1136/gutjnl-2012-302167] [Cited by in Crossref: 513] [Cited by in F6Publishing: 454] [Article Influence: 57.0] [Reference Citation Analysis]
27 Fraher MH, O'Toole PW, Quigley EM. Techniques used to characterize the gut microbiota: a guide for the clinician. Nat Rev Gastroenterol Hepatol. 2012;9:312-322. [PMID: 22450307 DOI: 10.1038/nrgastro.2012.44] [Cited by in Crossref: 203] [Cited by in F6Publishing: 186] [Article Influence: 22.6] [Reference Citation Analysis]
28 Kageyama Y, Shimokawa Y, Kawauchi K, Morimoto M, Aida K, Akiyama T, Nakamura T. Higher Prevalence of Nickel and Palladium Hypersensitivity in Patients with Ulcerative Colitis. Int Arch Allergy Immunol 2020;181:456-61. [PMID: 32316004 DOI: 10.1159/000506633] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Yuan F, Ni H, Asche CV, Kim M, Walayat S, Ren J. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis. Curr Med Res Opin. 2017;33:1191-1197. [PMID: 28166427 DOI: 10.1080/03007995.2017.1292230] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 8.8] [Reference Citation Analysis]
30 Arshad MS, Fatima S, Nazari K, Ali R, Farhan M, Muhammad SA, Abbas N, Hussain A, Kucuk I, Chang MW, Mehta P, Ahmad Z. Engineering and characterisation of BCG-loaded polymeric microneedles. J Drug Target 2020;28:525-32. [PMID: 31718314 DOI: 10.1080/1061186X.2019.1693577] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
31 Kamphuis JBJ, Guiard B, Leveque M, Olier M, Jouanin I, Yvon S, Tondereau V, Rivière P, Guéraud F, Chevolleau S, Noguer-Meireles MH, Martin JF, Debrauwer L, Eutamène H, Theodorou V. Lactose and Fructo-oligosaccharides Increase Visceral Sensitivity in Mice via Glycation Processes, Increasing Mast Cell Density in Colonic Mucosa. Gastroenterology 2020;158:652-663.e6. [PMID: 31711923 DOI: 10.1053/j.gastro.2019.10.037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
32 Singh R, Zogg H, Ro S. Role of microRNAs in Disorders of Gut-Brain Interactions: Clinical Insights and Therapeutic Alternatives. J Pers Med 2021;11:1021. [PMID: 34683162 DOI: 10.3390/jpm11101021] [Reference Citation Analysis]
33 Quigley EM. Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? Therap Adv Gastroenterol. 2016;9:199-212. [PMID: 26929782 DOI: 10.1177/1756283x15621230] [Cited by in Crossref: 42] [Cited by in F6Publishing: 16] [Article Influence: 8.4] [Reference Citation Analysis]
34 Kim SE, Chang L. Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? Neurogastroenterol Motil. 2012;24:895-913. [PMID: 22863120 DOI: 10.1111/j.1365-2982.2012.01993.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 68] [Article Influence: 8.3] [Reference Citation Analysis]
35 Muscatello MRA, Bruno A, Scimeca G, Pandolfo G, Zoccali RA. Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome. World J Gastroenterol 2014; 20(24): 7570-7586 [PMID: 24976697 DOI: 10.3748/wjg.v20.i24.7570] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
36 Perna E, Aguilera-Lizarraga J, Florens MV, Jain P, Theofanous SA, Hanning N, De Man JG, Berg M, De Winter B, Alpizar YA, Talavera K, Vanden Berghe P, Wouters M, Boeckxstaens G. Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS. Gut. 2020 epub ahead of print. [PMID: 33023902 DOI: 10.1136/gutjnl-2020-321530] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Ghouzali I, Azhar S, Bôle-feysot C, Ducrotté P, Déchelotte P, Coëffier M. Proteasome inhibitors exacerbate interleukin-8 production induced by protease-activated receptor 2 in intestinal epithelial cells. Cytokine 2016;86:41-6. [DOI: 10.1016/j.cyto.2016.07.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
38 Meerveld BG, Johnson AC. Mechanisms of Stress-induced Visceral Pain. J Neurogastroenterol Motil 2018;24:7-18. [PMID: 29291604 DOI: 10.5056/jnm17137] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 11.0] [Reference Citation Analysis]
39 van Wanrooij SJ, Wouters MM, Van Oudenhove L, Vanbrabant W, Mondelaers S, Kollmann P, Kreutz F, Schemann M, Boeckxstaens GE. Sensitivity testing in irritable bowel syndrome with rectal capsaicin stimulations: role of TRPV1 upregulation and sensitization in visceral hypersensitivity? Am J Gastroenterol. 2014;109:99-109. [PMID: 24189713 DOI: 10.1038/ajg.2013.371] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 7.0] [Reference Citation Analysis]
40 Cappelletti M, Tognon E, Vona L, Basello K, Costanzi A, Speciani MC, Speciani AF. Food-specific serum IgG and symptom reduction with a personalized, unrestricted-calorie diet of six weeks in Irritable Bowel Syndrome (IBS). Nutr Metab (Lond) 2020;17:101. [PMID: 33292297 DOI: 10.1186/s12986-020-00528-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 罗和生, 赵运志, 张法灿, 张国. 肥大细胞在肠易激综合征发病机制中的研究进展. 世界华人消化杂志 2012; 20(19): 1747-1751 [DOI: 10.11569/wcjd.v20.i19.1747] [Reference Citation Analysis]
42 Traina G. Mast Cells in Gut and Brain and Their Potential Role as an Emerging Therapeutic Target for Neural Diseases. Front Cell Neurosci 2019;13:345. [PMID: 31417365 DOI: 10.3389/fncel.2019.00345] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
43 König J, Brummer R. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Beneficial Microbes 2014;5:247-61. [DOI: 10.3920/bm2013.0033] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
44 Lee JY, Kim N, Kim YS, Nam RH, Ham MH, Lee HS, Jo W, Shim Y, Choi YJ, Yoon H, Shin CM, Lee DH. Repeated Water Avoidance Stress Alters Mucosal Mast Cell Counts, Interleukin-1β Levels with Sex Differences in the Distal Colon of Wistar Rats. J Neurogastroenterol Motil 2016;22:694-704. [PMID: 27466288 DOI: 10.5056/jnm16007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
45 Scalera A, Di Minno MND, Tarantino G. What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol 2013; 19(33): 5402-5420 [PMID: 24023483 DOI: 10.3748/wjg.v19.i33.5402] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
46 García Carrasco M, Mendoza Pinto C, López Colombo A, Méndez Martínez S, Andari Sawaya R, Muñoz Guarneros M, Vázquez De Lara L, Lescas Hernández M, Montiel Jarquín A, Ramos Álvarez G, Schmulson M. Irritable bowel syndrome-type symptoms in female patients with mild systemic lupus erythematosus: frequency, related factors and quality of life. Neurogastroenterol Motil 2013;25:958-66. [DOI: 10.1111/nmo.12230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
47 Fadgyas-Stanculete M, Buga AM, Popa-Wagner A, Dumitrascu DL. The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations. J Mol Psychiatry. 2014;2:4. [PMID: 25408914 DOI: 10.1186/2049-9256-2-4] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 10.4] [Reference Citation Analysis]
48 Hilmi I, Hartono JL, Pailoor J, Mahadeva S, Goh KL. Low prevalence of 'classical' microscopic colitis but evidence of microscopic inflammation in Asian irritable bowel syndrome patients with diarrhoea. BMC Gastroenterol 2013;13:80. [PMID: 23651739 DOI: 10.1186/1471-230X-13-80] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
49 Piscaglia AC, Laterza L, Cesario V, Gerardi V, Landi R, Lopetuso LR, Calò G, Fabbretti G, Brisigotti M, Stefanelli ML, Gasbarrini A. Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? World J Gastroenterol 2016; 22(46): 10198-10209 [PMID: 28028368 DOI: 10.3748/wjg.v22.i46.10198] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
50 Wilson D, Evans M, Weaver E, Shaw AL, Klein GL. Evaluation of serum-derived bovine immunoglobulin protein isolate in subjects with diarrhea-predominant irritable bowel syndrome. Clin Med Insights Gastroenterol 2013;6:49-60. [PMID: 24833942 DOI: 10.4137/CGast.S13200] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
51 Deiana S, Gabbani T, Bagnoli S, Annese V. Emerging drug for diarrhea predominant irritable bowel syndrome. Expert Opin Emerg Drugs 2015;20:247-61. [PMID: 25732091 DOI: 10.1517/14728214.2015.1013935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
52 Barbara G, Feinle-Bisset C, Ghoshal UC, Quigley EM, Santos J, Vanner S, Vergnolle N, Zoetendal EG. The Intestinal Microenvironment and Functional Gastrointestinal Disorders. Gastroenterology. 2016;150:1305-1318. [PMID: 27144620 DOI: 10.1053/j.gastro.2016.02.028] [Cited by in Crossref: 134] [Cited by in F6Publishing: 103] [Article Influence: 26.8] [Reference Citation Analysis]
53 Boyer J, Saint-paul M, Dadone B, Patouraux S, Vivinus M, Ouvrier D, Michiels J, Piche T, Tulic MK. Inflammatory cell distribution in colon mucosa as a new tool for diagnosis of irritable bowel syndrome: A promising pilot study. Neurogastroenterol Motil 2018;30:e13223. [DOI: 10.1111/nmo.13223] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
54 Barbara G, Cremon C, Stanghellini V. Inflammatory bowel disease and irritable bowel syndrome: similarities and differences. Curr Opin Gastroenterol. 2014;30:352-358. [PMID: 24811054 DOI: 10.1097/mog.0000000000000070] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
55 Du C, Peng L, Kou G, Wang P, Lu L, Li Y. Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome. Dig Dis Sci 2018;63:1182-91. [DOI: 10.1007/s10620-018-5002-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Hattay P, Prusator DK, Johnson AC, Greenwood-Van Meerveld B. Stereotaxic Exposure of the Central Nucleus of the Amygdala to Corticosterone Increases Colonic Permeability and Reduces Nerve-Mediated Active Ion Transport in Rats. Front Neurosci 2018;12:543. [PMID: 30154689 DOI: 10.3389/fnins.2018.00543] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
57 Kodani M, Fukui H, Tomita T, Oshima T, Watari J, Miwa H. Association between gastrointestinal motility and macrophage/mast cell distribution in mice during the healing stage after DSS‑induced colitis. Mol Med Rep 2018;17:8167-72. [PMID: 29693127 DOI: 10.3892/mmr.2018.8926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
58 Choi CH, Kwon JG, Kim SK, Myung SJ, Park KS, Sohn CI, Rhee PL, Lee KJ, Lee OY, Jung HK, Jee SR, Jeen YT, Choi MG, Choi SC, Huh KC, Park H. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial. Neurogastroenterol Motil. 2015;27:705-716. [PMID: 25809913 DOI: 10.1111/nmo.12544] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
59 Jones MP, Shah A, Walker MM, Koloski NA, Holtmann G, Talley NJ. Antibiotic use but not gastrointestinal infection frequently precedes first diagnosis of functional gastrointestinal disorders. United European Gastroenterol J 2021;9:1074-80. [PMID: 34653313 DOI: 10.1002/ueg2.12164] [Reference Citation Analysis]
60 Caviglia GP, Tucci A, Pellicano R, Fagoonee S, Rosso C, Abate ML, Olivero A, Armandi A, Vanni E, Saracco GM, Bugianesi E, Astegiano M, Ribaldone DG. Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report. J Clin Med 2020;9:E2353. [PMID: 32717980 DOI: 10.3390/jcm9082353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
61 Fan L, Wong M, Fan XS, Hong Y, Sun K, Jiang C, Xie X, Wang HL. Quantitative Analysis of Intramucosal Mast Cells in Irritable Bowel Syndrome: A Comparison With Inflammatory Bowel Disease in Remission. J Clin Gastroenterol 2021;55:244-9. [PMID: 32649443 DOI: 10.1097/MCG.0000000000001394] [Reference Citation Analysis]
62 Lee JY, Kim N, Park JH, Nam RH, Lee SM, Song CH, Kim G, Na HY, Choi YJ, Kim JJ, Lee DH. Expression of Neurotrophic Factors, Tight Junction Proteins, and Cytokines According to the Irritable Bowel Syndrome Subtype and Sex. J Neurogastroenterol Motil 2020;26:106-16. [PMID: 31623029 DOI: 10.5056/jnm19099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
63 Barbara G, Cremon C, Annese V, Basilisco G, Bazzoli F, Bellini M, Benedetti A, Benini L, Bossa F, Buldrini P. Randomised controlled trial of mesalazine in IBS. Gut. 2016;65:82-90. [PMID: 25533646 DOI: 10.1136/gutjnl-2014-308188] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 8.3] [Reference Citation Analysis]
64 Catinean A, Neag AM, Nita A, Buzea M, Buzoianu AD. Bacillus spp. Spores-A Promising Treatment Option for Patients with Irritable Bowel Syndrome. Nutrients 2019;11:E1968. [PMID: 31438618 DOI: 10.3390/nu11091968] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
65 Kwon YH, Kim HJ. [Current Status of Translational Research on Irritable Bowel Syndrome]. Korean J Gastroenterol 2016;68:138-42. [PMID: 27646582 DOI: 10.4166/kjg.2016.68.3.138] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
66 Shukla R, Ghoshal U, Dhole TN, Ghoshal UC. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis. Dig Dis Sci. 2015;60:2953-2962. [PMID: 25784074 DOI: 10.1007/s10620-015-3607-y] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 12.2] [Reference Citation Analysis]
67 Jonefjäll B, Strid H, Ohman L, Svedlund J, Bergstedt A, Simren M. Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission. Neurogastroenterol Motil. 2013;25:756-e578. [PMID: 23731196 DOI: 10.1111/nmo.12163] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 6.0] [Reference Citation Analysis]
68 Carroccio A, Mansueto P, Morfino G, D'alcamo A, Di Paola V, Iacono G, Soresi M, Scerrino G, Maresi E, Gulotta G, Rini G, Bonventre S. Oligo-Antigenic Diet in the Treatment of Chronic Anal Fissures. Evidence for a Relationship Between Food Hypersensitivity and Anal Fissures. American Journal of Gastroenterology 2013;108:825-32. [DOI: 10.1038/ajg.2013.58] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
69 Ratanasirintrawoot S, Israsena N. Stem Cells in the Intestine: Possible Roles in Pathogenesis of Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2016;22:367-382. [PMID: 27184041 DOI: 10.5056/jnm16023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
70 Dothel G, Barbaro MR, Boudin H, Vasina V, Cremon C, Gargano L, Bellacosa L, De Giorgio R, Le Berre-Scoul C, Aubert P, Neunlist M, De Ponti F, Stanghellini V, Barbara G. Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology. 2015;148:1002-1011.e4. [PMID: 25655556 DOI: 10.1053/j.gastro.2015.01.042] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 14.2] [Reference Citation Analysis]
71 Theoharides TC, Asadi S, Chen J, Huizinga JD. Irritable bowel syndrome and the elusive mast cells. Am J Gastroenterol. 2012;107:727-729. [PMID: 22552242 DOI: 10.1038/ajg.2012.61] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
72 O’Malley D, Buckley MM, McKernan DP, Quigley EM, Cryan JF, Dinan TG. Soluble mediators in plasma from irritable bowel syndrome patients excite rat submucosal neurons. Brain Behav Immun. 2015;44:57-67. [PMID: 25150006 DOI: 10.1016/j.bbi.2014.08.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
73 Conte C, Sichetti M, Traina G. Gut–Brain Axis: Focus on Neurodegeneration and Mast Cells. Applied Sciences 2020;10:1828. [DOI: 10.3390/app10051828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
74 Volta U, Pinto-Sanchez MI, Boschetti E, Caio G, De Giorgio R, Verdu EF. Dietary Triggers in Irritable Bowel Syndrome: Is There a Role for Gluten? J Neurogastroenterol Motil. 2016;22:547-557. [PMID: 27426486 DOI: 10.5056/jnm16069] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 8.2] [Reference Citation Analysis]
75 [DOI: 10.1101/2021.03.29.437589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Lied GA. Indication of Immune Activation in Patients with Perceived Food Hypersensitivity. Dig Dis Sci 2014;59:259-66. [DOI: 10.1007/s10620-013-2926-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
77 Ayadilord M, Mahmoudzadeh S, Hoseini ZS, Askari M, Rezapour H, Saharkhiz M, Abbaszadeh A, Karbasi S, Zandi Dashtebayaze N, Ferns GA, Bahrami A. Neuropsychological function is related to irritable bowel syndrome in women with premenstrual syndrome and dysmenorrhea. Arch Gynecol Obstet 2020;302:915-23. [PMID: 32594296 DOI: 10.1007/s00404-020-05659-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
78 Riba A, Olier M, Lacroix-Lamandé S, Lencina C, Bacquié V, Harkat C, Van Langendonck N, Gillet M, Cartier C, Baron M, Sommer C, Mallet V, Zill M, Robert H, Laurent F, Ellero-Simatos S, Théodorou V, Ménard S. Early life stress in mice is a suitable model for Irritable Bowel Syndrome but does not predispose to colitis nor increase susceptibility to enteric infections. Brain Behav Immun 2018;73:403-15. [PMID: 29860025 DOI: 10.1016/j.bbi.2018.05.024] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
79 Jovani M, Fiorino G, Danese S. Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome. Aliment Pharmacol Ther. 2013;37:277-278. [PMID: 23252779 DOI: 10.1111/apt.12136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
80 Leccioli V, Oliveri M, Romeo M, Berretta M, Rossi P. A New Proposal for the Pathogenic Mechanism of Non-Coeliac/Non-Allergic Gluten/Wheat Sensitivity: Piecing Together the Puzzle of Recent Scientific Evidence. Nutrients 2017;9:E1203. [PMID: 29099090 DOI: 10.3390/nu9111203] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
81 Dekel R, Drossman DA, Sperber AD. The use of psychotropic drugs in irritable bowel syndrome. Expert Opin Investig Drugs. 2013;22:329-339. [PMID: 23316916 DOI: 10.1517/13543784.2013.761205] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
82 Kumar S, Shukla R, Ranjan P, Kumar A. Interleukin-10: A Compelling Therapeutic Target in Patients With Irritable Bowel Syndrome. Clin Ther 2017;39:632-43. [PMID: 28237672 DOI: 10.1016/j.clinthera.2017.01.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
83 Vanner S, Greenwood-Van Meerveld B, Mawe G, Shea-Donohue T, Verdu EF, Wood J, Grundy D. Fundamentals of Neurogastroenterology: Basic Science. Gastroenterology. 2016;150:1280-1291. [PMID: 27144618 DOI: 10.1053/j.gastro.2016.02.018] [Cited by in Crossref: 65] [Cited by in F6Publishing: 36] [Article Influence: 13.0] [Reference Citation Analysis]
84 Carco C, Young W, Gearry RB, Talley NJ, McNabb WC, Roy NC. Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis. Front Cell Infect Microbiol 2020;10:468. [PMID: 33014892 DOI: 10.3389/fcimb.2020.00468] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
85 Lee KN, Lee OY. The Role of Mast Cells in Irritable Bowel Syndrome. Gastroenterol Res Pract. 2016;2016:2031480. [PMID: 28115927 DOI: 10.1155/2016/2031480] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
86 Lee JY, Chu SH, Jeon JY, Lee MK, Park JH, Lee DC, Lee JW, Kim NK. Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: a double-blind, randomized, placebo-controlled trial. Dig Liver Dis 2014;46:1126-32. [PMID: 25442120 DOI: 10.1016/j.dld.2014.09.004] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 8.0] [Reference Citation Analysis]
87 Söderquist F, Syk M, Just D, Kurbalija Novicic Z, Rasmusson AJ, Hellström PM, Ramklint M, Cunningham JL. A cross-sectional study of gastrointestinal symptoms, depressive symptoms and trait anxiety in young adults. BMC Psychiatry 2020;20:535. [PMID: 33176747 DOI: 10.1186/s12888-020-02940-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
88 Eady SL, Wallace AJ, Hedderley DI, Bentley-hewitt KL, Butts CA. The Effects on Immune Function and Digestive Health of Consuming the Skin and Flesh of Zespri® SunGold Kiwifruit (Actinidia Chinensis var. Chinensis ‘Zesy002’) in Healthy and IBS-Constipated Individuals. Nutrients 2020;12:1453. [DOI: 10.3390/nu12051453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Rodríguez-Nogales A, Algieri F, Vezza T, Garrido-Mesa J, Molina-Tijeras JA, Rodríguez-Cabezas ME, Utrilla MP, Pischel I, Gálvez J. Calcium Pyruvate Exerts Beneficial Effects in an Experimental Model of Irritable Bowel Disease Induced by DCA in Rats. Nutrients 2019;11:E140. [PMID: 30634696 DOI: 10.3390/nu11010140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
90 Ilchmann-Diounou H, Menard S. Psychological Stress, Intestinal Barrier Dysfunctions, and Autoimmune Disorders: An Overview. Front Immunol 2020;11:1823. [PMID: 32983091 DOI: 10.3389/fimmu.2020.01823] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
91 Miri MB, Sadeghi A, Moradi A, Rostami-Nejad M, Asadzadeh Aghdaei H, Ehsani Ardekani MJ, Safari MT, Zali MR. Quantitation of Colonic Cells as Severity Markers in Patients with Irritable Bowel Syndrome. Galen Med J 2018;7:e1063. [PMID: 34466429 DOI: 10.22086/gmj.v0i0.1063] [Reference Citation Analysis]
92 Qian Q, Li P, Wang T, Zhang J, Yu S, Chen T, Yan L, Song Y, Liu X, Gu Y, Wang Y, Jia G. Alteration of Th1/Th2/Th17 cytokine profile and humoral immune responses associated with chromate exposure. Occup Environ Med 2013;70:697-702. [PMID: 23811143 DOI: 10.1136/oemed-2013-101421] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
93 Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, Tilg H, Watson A, Wells JM. Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14:189. [PMID: 25407511 DOI: 10.1186/s12876-014-0189-7] [Cited by in Crossref: 695] [Cited by in F6Publishing: 634] [Article Influence: 99.3] [Reference Citation Analysis]
94 De Giorgio R, Volta U, Gibson PR. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction? Gut. 2016;65:169-178. [PMID: 26078292 DOI: 10.1136/gutjnl-2015-309757] [Cited by in Crossref: 112] [Cited by in F6Publishing: 95] [Article Influence: 18.7] [Reference Citation Analysis]
95 Fukui H, Xu X, Miwa H. Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders. J Neurogastroenterol Motil 2018;24:367-86. [PMID: 29969855 DOI: 10.5056/jnm18071] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
96 Shin A, Preidis GA, Shulman R, Kashyap PC. The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders. Clin Gastroenterol Hepatol 2019;17:256-74. [PMID: 30153517 DOI: 10.1016/j.cgh.2018.08.054] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 15.7] [Reference Citation Analysis]
97 Lee SH, Joo NS, Kim KM, Kim KN. The Therapeutic Effect of a Multistrain Probiotic on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study. Gastroenterol Res Pract 2018;2018:8791916. [PMID: 30622561 DOI: 10.1155/2018/8791916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
98 Cuomo R, Barbara G, Pace F, Annese V, Bassotti G, Binda GA, Casetti T, Colecchia A, Festi D, Fiocca R, Laghi A, Maconi G, Nascimbeni R, Scarpignato C, Villanacci V, Annibale B. Italian consensus conference for colonic diverticulosis and diverticular disease. United European Gastroenterol J 2014;2:413-42. [PMID: 25360320 DOI: 10.1177/2050640614547068] [Cited by in Crossref: 90] [Cited by in F6Publishing: 72] [Article Influence: 12.9] [Reference Citation Analysis]
99 Lee SH, Cho DY, Lee SH, Han KS, Yang SW, Kim JH, Lee SH, Kim SM, Kim KN. A Randomized Clinical Trial of Synbiotics in Irritable Bowel Syndrome: Dose-Dependent Effects on Gastrointestinal Symptoms and Fatigue. Korean J Fam Med 2019;40:2-8. [PMID: 30360032 DOI: 10.4082/kjfm.17.0064] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
100 McIntosh K, Reed DE, Schneider T, Dang F, Keshteli AH, De Palma G, Madsen K, Bercik P, Vanner S. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut. 2017;66:1241-1251. [PMID: 26976734 DOI: 10.1136/gutjnl-2015-311339] [Cited by in Crossref: 194] [Cited by in F6Publishing: 179] [Article Influence: 38.8] [Reference Citation Analysis]
101 Bennet SM, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver. 2015;9:318-331. [PMID: 25918261 DOI: 10.5009/gnl14344] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 15.6] [Reference Citation Analysis]
102 Foxx-Orenstein AE. New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists. Therap Adv Gastroenterol 2016;9:354-75. [PMID: 27134665 DOI: 10.1177/1756283X16633050] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
103 Chow CFW, Che S, Qin HY, Kwan HY, Bian ZX, Wong HLX. From psychology to physicality: how nerve growth factor transduces early life stress into gastrointestinal motility disorders later in life. Cell Cycle 2019;18:1824-9. [PMID: 31272268 DOI: 10.1080/15384101.2019.1637203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
104 Singh R, Salem A, Nanavati J, Mullin GE. The Role of Diet in the Treatment of Irritable Bowel Syndrome: A Systematic Review. Gastroenterol Clin North Am 2018;47:107-37. [PMID: 29413008 DOI: 10.1016/j.gtc.2017.10.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
105 Soncini M, Stasi C, Usai Satta P, Milazzo G, Bianco M, Leandro G, Montalbano LM, Muscatiello N, Monica F, Galeazzi F, Bellini M; AIGO. IBS clinical management in Italy: The AIGO survey. Dig Liver Dis 2019;51:782-9. [PMID: 30448159 DOI: 10.1016/j.dld.2018.10.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
106 Abbasnezhad A, Amani R, Hajiani E, Alavinejad P, Cheraghian B, Ghadiri A. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: A randomized double-blind clinical trial. Neurogastroenterol Motil. 2016;28:1533-1544. [PMID: 27154424 DOI: 10.1111/nmo.12851] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
107 Bashashati M, Schmulson MJ. From gene polymorphisms to serum cytokine levels in irritable bowel syndrome. Clinics and Research in Hepatology and Gastroenterology 2016;40:525-7. [DOI: 10.1016/j.clinre.2016.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
108 Guzylack-Piriou L, Ménard S. Early Life Exposure to Food Contaminants and Social Stress as Risk Factor for Metabolic Disorders Occurrence?-An Overview. Biomolecules 2021;11:687. [PMID: 34063694 DOI: 10.3390/biom11050687] [Reference Citation Analysis]
109 Giancola F, Volta U, Repossi R, Latorre R, Beeckmans D, Carbone F, Van den Houte K, Bianco F, Bonora E, Gori A, Costanzini A, Boschetti E, Caio G, Vanuytsel T, Stanghellini V, Tack J, De Giorgio R. Mast cell-nerve interactions correlate with bloating and abdominal pain severity in patients with non-celiac gluten / wheat sensitivity. Neurogastroenterol Motil 2020;32:e13814. [PMID: 32022388 DOI: 10.1111/nmo.13814] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
110 Simon E, Călinoiu LF, Mitrea L, Vodnar DC. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome. Nutrients 2021;13:2112. [PMID: 34203002 DOI: 10.3390/nu13062112] [Reference Citation Analysis]
111 Zhang L, Song J, Hou X. Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside. J Neurogastroenterol Motil. 2016;22:181-192. [PMID: 26755686 DOI: 10.5056/jnm15137] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 13.0] [Reference Citation Analysis]
112 Shajib MS, Baranov A, Khan WI. Diverse Effects of Gut-Derived Serotonin in Intestinal Inflammation. ACS Chem Neurosci 2017;8:920-31. [DOI: 10.1021/acschemneuro.6b00414] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 8.3] [Reference Citation Analysis]